Ventricular conduction and long-term heart failure outcomes and mortality in African Americans: Insights from the Jackson heart study

Circulation: Heart Failure

Volumn 8, Issue 2, 2015, Pages 243-251

  Mentz, Robert J ^a,b   Greiner, Melissa A ^b   Devore, Adam D ^a,b   Dunlay, Shannon M ^c   Choudhary, Gaurav ^d   Ahmad, Tariq ^a   Khazanie, Prateeti ^a   Randolph, Tiffany C ^a,b   Griswold, Michael E ^e   Eapen, Zubin J ^a,b   O'Brien, Emily C ^a,b   Thomas, Kevin L ^a,b   Curtis, Lesley H ^b   Hernandez, Adrian F ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

African American; heart failure; mortality; ventricular conduction

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE CONDUCTION; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QRS INTERVAL; ETHNOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONDUCTION SYSTEM; HEART STROKE VOLUME; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; FEMALE; HEART CONDUCTION SYSTEM; HEART FAILURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84937566247     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001729     Document Type: Article

References (27)

1. Dhingra R, Pencina MJ, Wang TJ, Nam BH, Benjamin EJ, Levy D, Larson MG, Kannel WB, D'Agostino RB Jr, Vasan RS. Electrocardiographic QRS duration and the risk of congestive heart failure: the Framingham Heart Study. Hypertension. 2006;47:861-867. doi: 10.1161/01. HYP.0000217141.20163.23.
2. Morin DP, Oikarinen L, Viitasalo M, Toivonen L, Nieminen MS, Kjeldsen SE, Dahlöf B, John M, Devereux RB, Okin PM. QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study. Eur Heart J. 2009;30:2908-2914. doi: 10.1093/eurheartj/ehp321.
3. Aro AL, Anttonen O, Tikkanen JT, Junttila MJ, Kerola T, Rissanen HA, Reunanen A, Huikuri HV. Intraventricular conduction delay in a standard 12-lead electrocardiogram as a predictor of mortality in the general population. Circ Arrhythm Electrophysiol. 2011;4:704-710. doi: 10.1161/CIRCEP.111.963561.
4. Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol. 2005;46:2183-2192. doi: 10.1016/j.jacc.2005.01.071.
5. Wang NC, Maggioni AP, Konstam MA, Zannad F, Krasa HB, Burnett JC Jr, Grinfeld L, Swedberg K, Udelson JE, Cook T, Traver B, Zimmer C, Orlandi C, Gheorghiade M; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA. 2008;299:2656-2666. doi: 10.1001/jama.299.22.2656.
6. Zimetbaum PJ, Buxton AE, Batsford W, Fisher JD, Hafley GE, Lee KL, O'Toole MF, Page RL, Reynolds M, Josephson ME. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation. 2004;110:766-769. doi: 10.1161/01.CIR.0000139311.32278.32.
7. Bongioanni S, Bianchi F, Migliardi A, Gnavi R, Pron PG, Casetta M, Conte MR. Relation of QRS duration to mortality in a community-based cohort with hypertrophic cardiomyopathy. Am J Cardiol. 2007;100:503-506. doi: 10.1016/j.amjcard.2007.03.049.
8. Badheka AO, Singh V, Patel NJ, Deshmukh A, Shah N, Chothani A, Mehta K, Grover P, Savani GT, Gupta S, Rathod A, Marzouka GR, Mitrani RD, Moscucci M, Cohen MG. QRS duration on electrocardiography and cardiovascular mortality (from the National Health and Nutrition Examination Survey-III). Am J Cardiol. 2013;112:671-677. doi: 10.1016/j.amjcard.2013.04.040.
9. Ilkhanoff L, Soliman EZ, Ning H, Liu K, Lloyd-Jones DM. Factors associated with development of prolonged QRS duration over 20 years in healthy young adults: the Coronary Artery Risk Development in Young Adults study. J Electrocardiol. 2012;45:178-184. doi: 10.1016/j. jelectrocard.2011.11.001.
10. Mentz RJ, Bittner V, Schulte PJ, Fleg JL, Pinã IL, Keteyian SJ, Moe G, Nigam A, Swank AM, Onwuanyi AE, Fitz-Gerald M, Kao A, Ellis SJ, Kraus WE, Whellan DJ, O'Connor CM. Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure-A Controlled Trial Investigating Outcomes in Exercise Training (HFACTION). Am Heart J. 2013; 166:488-495.e481.
11. Taylor HA Jr. The Jackson Heart Study: an overview. Ethn Dis. 2005; 15:S6-1-S6-3.
12. Fox ER, Musani SK, Bidulescu A, Nagarajarao HS, Samdarshi TE, Gebreab SY, Sung JH, Steffes MW, Wang TJ, Taylor HA, Vasan RS. Relation of obesity to circulating B-type natriuretic peptide concentrations in blacks: the Jackson Heart Study. Circulation. 2011;124:1021-1027. doi: 10.1161/CIRCULATIONAHA.110.991943.
13. Carpenter MA, Crow R, Steffes M, Rock W, Heilbraun J, Evans G, Skelton T, Jensen R, Sarpong D. Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study. Am J Med. Sci. 2004;328:131-144.
14. Wyatt SB, Akylbekova EL, Wofford MR, Coady SA, Walker ER, Andrew ME, Keahey WJ, Taylor HA, Jones DW. Prevalence, awareness, treatment, and control of hypertension in the Jackson Heart Study. Hypertension. 2008;51:650-656. doi: 10.1161/HYPERTENSIONAHA. 107.100081.
15. Akylbekova EL, Crow RS, Johnson WD, Buxbaum SG, Njemanze S, Fox E, Sarpong DF, Taylor HA, Newton-Cheh C. Clinical correlates and heritability of QT interval duration in blacks: the Jackson Heart Study. Circ Arrhythm Electrophysiol. 2009;2:427-432. doi: 10.1161/CIRCEP.109.858894.
16. Keku E, Rosamond W, Taylor HA Jr, Garrison R, Wyatt SB, Richard M, Jenkins B, Reeves L, Sarpong D. Cardiovascular disease event classification in the Jackson Heart Study: methods and procedures. Ethn Dis. 2005;15(4 Suppl 6):S6-62.
17. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147-e239. doi: 10.1016/j.jacc.2013.05.019.
18. Avery CL, Mills KT, Chambless LE, Chang PP, Folsom AR, Mosley TH, Ni H, Rosamond WD, Wagenknecht L, Wood J, Heiss G. Longterm association between self-reported signs and symptoms and heart failure hospitalizations: the Atherosclerosis Risk In Communities (ARIC) Study. Eur J Heart Fail. 2010;12:232-238. doi: 10.1093/eurjhf/hfp203.
19. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702-706.
20. Breslow NE, Day NE. Statistical methods in cancer research. Volume II-the design and analysis of cohort studies. IARC Sci Publ. 1987;(82):1-406.
21. Hebert K, Quevedo HC, Tamariz L, Dias A, Steen DL, Colombo RA, Franco E, Neistein S, Arcement LM. Prevalence of conduction abnormalities in a systolic heart failure population by race, ethnicity, and gender. Ann Noninvasive Electrocardiol. 2012;17:113-122. doi: 10.1111/j.1542-474X.2012.00492.x.
22. Walsh JA III, Prineas R, Daviglus ML, Ning H, Liu K, Lewis CE, Sidney S, Schreiner PJ, Iribarren C, Lloyd-Jones DM. Prevalence of electrocardiographic abnormalities in a middle-aged, biracial population: Coronary Artery Risk Development in Young Adults study. J Electrocardiol. 2010;43:385.e1-385.e9. doi: 10.1016/j.jelectrocard.2010.02.001.
23. Katibi I, Clark E, Devine B, Lloyd S, Macfarlane PW. Comparison of QRS duration in African blacks and European Caucasians. Comput Cardiol. 2010;37:701-704.
24. Jeff JM, Brown-Gentry K, Buxbaum SG, Sarpong DF, Taylor HA, George AL Jr, Roden DM, Crawford DC. SCN5A variation is associated with electrocardiographic traits in the Jackson Heart Study. Circ Cardiovasc Genet. 2011;4:139-144. doi: 10.1161/CIRCGENETICS.110.958124.
25. Bussink BE, Holst AG, Jespersen L, Deckers JW, Jensen GB, Prescott E. Right bundle branch block: prevalence, risk factors, and outcome in the general population: results from the Copenhagen City Heart Study. Eur Heart J. 2013;34:138-146. doi: 10.1093/eurheartj/ehs291.
26. Fleg JL, Das DN, Lakatta EG. Right bundle branch block: long-term prognosis in apparently healthy men. J Am Coll Cardiol. 1983;1:887-892.
27. Sotoodehnia N, Isaacs A, de Bakker PI, Dörr M, Newton-Cheh C, Nolte IM, van der Harst P, Müller M, Eijgelsheim M, Alonso A, Hicks AA, Padmanabhan S, Hayward C, Smith AV, Polasek O, Giovannone S, Fu J, Magnani JW, Marciante KD, Pfeufer A, Gharib SA, Teumer A, Li M, Bis JC, Rivadeneira F, Aspelund T, Köttgen A, Johnson T, Rice K, Sie MP, Wang YA, Klopp N, Fuchsberger C, Wild SH, Mateo Leach I, Estrada K, Völker U, Wright AF, Asselbergs FW, Qu J, Chakravarti A, Sinner MF, Kors JA, Petersmann A, Harris TB, Soliman EZ, Munroe PB, Psaty BM, Oostra BA, Cupples LA, Perz S, de Boer RA, Uitterlinden AG, Völzke H, Spector TD, Liu FY, Boerwinkle E, Dominiczak AF, Rotter JI, van Herpen G, Levy D, Wichmann HE, van Gilst WH, Witteman JC, Kroemer HK, Kao WH, Heckbert SR, Meitinger T, Hofman A, Campbell H, Folsom AR, van Veldhuisen DJ, Schwienbacher C, O'Donnell CJ, Volpato CB, Caulfield MJ, Connell JM, Launer L, Lu X, Franke L, Fehrmann RS, te Meerman G, Groen HJ, Weersma RK, van den Berg LH, Wijmenga C, Ophoff RA, Navis G, Rudan I, Snieder H, Wilson JF, Pramstaller PP, Siscovick DS, Wang TJ, Gudnason V, van Duijn CM, Felix SB, Fishman GI, Jamshidi Y, Stricker BH, Samani NJ, Kaäb S, Arking DE. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet. 2010;42:1068-1076. doi: 10.1038/ng.716.